{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:38Z","timestamp":1790753858201,"version":"4.1.0"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,26]]},"DOI":"10.18632\/oncotarget.20622","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T05:56:24Z","timestamp":1504331784000},"page":"73433-73447","source":"Crossref","is-referenced-by-count":36,"title":["Central role of mTORC1 downstream of YAP\/TAZ in hepatoblastoma development"],"prefix":"10.18632","volume":"8","author":[{"given":"Pin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"},{"name":"Department of Bioengineering and Therapeutic Sciences, Liver Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"Calvisi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Kiss","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cigliano","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences, Liver Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ribback","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Dombrowski","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences, Liver Center, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Birch","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jpedsurg.2014.12.010","article-title":"Trends in incidence of childhood malignant solid tumors in Japan: Estimation based on hospital-based registration","volume":"50","author":"Nakamura","year":"2015","journal-title":"J Pediatr Surg"},{"key":"3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6061\/clinics\/2015(06)01","article-title":"New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years","volume":"70","author":"Tannuri","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/mop.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Meyers","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/hep.27243","article-title":"Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex","volume":"60","author":"Xia","year":"2014","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.gastro.2005.04.013","article-title":"Epidermal growth factor receptor: a novel target of the Wnt\/beta-catenin pathway in liver","volume":"129","author":"Monga","year":"2005","journal-title":"Gastroenterology"},{"key":"7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Levillayer","year":"2008","journal-title":"Cancer Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/hep.27347","article-title":"Mutational landscape of hepatoblastoma goes beyond the Wnt-beta-catenin pathway","volume":"60","author":"Han","year":"2014","journal-title":"Hepatology"},{"key":"9","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Liu","year":"2002","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3835(99)00433-4","article-title":"Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma","volume":"152","author":"Hsu","year":"2000","journal-title":"Cancer Lett"},{"key":"11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and YAP1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Evert","year":"2014","journal-title":"Gastroenterology"},{"key":"12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Sabatini","year":"2017","journal-title":"Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.26323","article-title":"The mTOR pathway in hepatic malignancies","volume":"58","author":"Gores","year":"2013","journal-title":"Hepatology"},{"key":"15","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","article-title":"Pivotal role of mTOR signaling in hepatocellular carcinoma","volume":"135","author":"Fiel","year":"2008","journal-title":"Gastroenterology"},{"key":"16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1634\/theoncologist.2009-0178","article-title":"FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma","volume":"15","author":"Pazdur","year":"2010","journal-title":"Oncologist"},{"key":"17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","article-title":"Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends","volume":"60","author":"Thorgeirsson","year":"2014","journal-title":"J Hepatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/pbc.22187","article-title":"Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor","volume":"53","author":"Tomlinson","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"Knowles","year":"2009","journal-title":"Hum Pathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Martin","year":"2012","journal-title":"Nature"},{"key":"21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.27396","article-title":"4EBP1\/eIF4E and p70S6K\/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice","volume":"61","author":"Evert","year":"2015","journal-title":"Hepatology"},{"key":"22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hep.28223","article-title":"Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma","volume":"63","author":"Jang","year":"2016","journal-title":"Hepatology"},{"key":"23","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1158\/1078-0432.ccr-08-2878","article-title":"Activation of phosphatidylinositol-3\u2019-kinase\/AKT signaling is essential in hepatoblastoma survival","volume":"15","author":"Buettner","year":"2009","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.ejca.2011.12.032","article-title":"Rapamycin blocks hepatoblastoma growthandimplicating new treatment options in high-risk patients","volume":"48","author":"Kappler","year":"2012","journal-title":"Eur J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1053\/j.gastro.2017.02.018","article-title":"Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer","volume":"152","author":"Gretz","year":"2017","journal-title":"Gastroenterology"},{"key":"26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A Call for Systematic Research on Solute Carriers","volume":"162","author":"Superti-Furga","year":"2015","journal-title":"Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1158\/0008-5472.can-14-3745","article-title":"Amino Acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: novel targets for the design of a new class of anticancer drugs","volume":"75","author":"Ganapathy","year":"2015","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2016.03.013","article-title":"Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot","volume":"23","author":"Harris","year":"2016","journal-title":"Cell Metab"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29183","article-title":"A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis","author":"Brozzetti","year":"2017","journal-title":"Hepatology"},{"key":"30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1078-0432.ccr-12-2334","article-title":"SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival","volume":"19","author":"Massion","year":"2013","journal-title":"Clin Cancer Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.mam.2012.07.015","article-title":"Solute carriers as drug targets: current use, clinical trials and prospective","volume":"34","author":"Schioth","year":"2013","journal-title":"Mol Aspects Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nature09584","article-title":"mTORC1 controls fasting-induced ketogenesis and its modulation by ageing","volume":"468","author":"Sabatini","year":"2010","journal-title":"Nature"},{"key":"33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","article-title":"Hydrodynamic transfection for generation of novel mouse models for liver cancer research","volume":"184","author":"Calvisi","year":"2014","journal-title":"Am J Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:50:41Z","timestamp":1589197841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":33,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2017,9,26]]}},"alternative-id":["20622","29088718"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20622","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}